Article Detail

Home > Article Detail
  • P-ISSN 2233-4203
  • E-ISSN 2093-8950

Characterization of in vitro Metabolites of Methylenedioxy Designer Drugs

Mass Spectrometry Letters / Mass Spectrometry Letters, (P)2233-4203; (E)2093-8950
2023, v.14 no.1, pp.1-8
https://doi.org/10.5478/MSL.2023.14.1.1
Yu Jun Sang (Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University)
Jo So Young (Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University)
Park Il-Ho (College of Pharmacy, Sahmyook University)
Yoo Hye Hyun (Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University)

  • Downloaded
  • Viewed

Abstract

Eutylone, dibutylone, and dimethylone are potential psychotropic designer drugs. The purpose of this study was to investigate the in vitro metabolic pathways of synthetic cathinones with methylenedioxy groups. The three methylenedioxy derivatives were incubated with human liver microsomes. The metabolites were characterized based on liquid chromatography and quadrupole-time-of-flight mass spectrometry. Eutylone, dibutylone, and dimethylone were metabolized to yield three, six, and four metabolites, respectively. Reduction and demethylenation were the major metabolic pathways for all three drugs tested. However, dibutylone and dimethylone showed an additional metabolite generated via N-oxidation. These results provide evi- dence for the in vivo metabolism of methylenedioxy synthetic cathinones, and could be applied to the analysis of synthetic cathi- nones and their relevant metabolites in biological samples.

keywords
Methylenedioxy derivatives, Designer drug, Metabolism, LC/Q-TOF MS


Submission Date
2023-02-10
Revised Date
2023-03-04
Accepted Date
2023-03-09
상단으로 이동

Mass Spectrometry Letters